VNDA

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is a biopharmaceutical company founded in 2002 and headquartered in Washington, D.C. The company went public in April 2006 and focuses on developing and commercializing therapies to address high unmet medical needs, particularly in the areas of sleep disorders, psychiatric conditions, and other central nervous system disorders. Vanda has successfully brought several products to market and maintains a robust pipeline of investigational therapies across multiple therapeutic areas.